LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, ...

Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Motorists are being alerted to an important date that’s fast-approaching. On social media, the DVLA Personalised Registration ...

A special group of drivers have been issued a heads-up about an imminent deadline - yes, that's right all you Amys out there.

A specific group of drivers have been given a heads-up about an upcoming deadline - yes, that's right, all you Amys out there ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

The real estate narrative in the National Capital Region (NCR) is shifting. The momentum of residential growth is increasingly being fuelled by peripheral towns and micro-markets — not the traditional ...

Figure 1: Serine elastase inhibition induces survival by reversal of pulmonary hypertension. Inhibition of serine elastase activity reversed the progressive mortality of untreated or vehicle-treated ...